Cases 11 - 20 of 404
Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc.
as 23-2254
Plaintiff / Appellee:
MERCK SHARP & DOHME B.V. and MERCK SHARP & DOHME, LLC
Defendant / Appellant:
AUROBINDO PHARMA USA, INC., AUROBINDO PHARMA LTD., USV PRIVATE LIMITED and others
Defendant:
LUPIN LTD., LUPIN PHARMACEUTICALS, INC. and LUPIN INC.
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al
as 1:2023cv00556
Plaintiff:
Mylan Pharmaceuticals Inc.
Defendant:
Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.
as 1:2023cv00033
Counter Defendant:
Abraxis Bioscience, LLC
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk, Inc. et al v. Viatris Inc. et al
as 1:2023cv00013
Plaintiff:
Novo Nordisk, Inc. and Novo Nordisk A/S
Defendant:
Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Viatris Inc. et al
as 1:2023cv00101
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AstraZeneca AB v. Mylan Pharmaceuticals Inc.
as 23-1267
Plaintiff / Appellee:
ASTRAZENECA AB and ASTRAZENECA PHARMACEUTICALS LP
Defendant / Appellant:
MYLAN PHARMACEUTICALS INC. and KINDEVA DRUG DELIVERY L.P.
AstraZeneca AB v. Mylan Pharmaceuticals Inc.
as 23-1164
Plaintiff / Appellant:
ASTRAZENECA AB and ASTRAZENECA PHARMACEUTICALS LP
Defendant / Appellee:
MYLAN PHARMACEUTICALS INC. and KINDEVA DRUG DELIVERY L.P.
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv00114
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01395
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Otsuka Pharmaceutical Co., Ltd. et al v. Mylan Laboratories Limited et al
as 1:2022cv01367
Plaintiff:
Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Defendant:
Mylan Laboratories Limited, Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
